News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,781 Results
Type
Article (2492)
Company Profile (39)
Press Release (36250)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14207)
Career Advice (81)
Deals (2088)
Drug Delivery (9)
Drug Development (4160)
Employer Resources (11)
FDA (456)
Job Trends (773)
News (20326)
Policy (1076)
Tag
Academia (147)
Allergies (6)
Alliances (3490)
ALS (4)
Alzheimer's disease (49)
Antibody-drug conjugate (ADC) (18)
Approvals (458)
Artificial intelligence (13)
Autoimmune disease (3)
Automation (2)
Bankruptcy (12)
Best Places to Work (480)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (151)
Cardiovascular disease (5)
Career advice (68)
Career pathing (1)
CAR-T (16)
Cell therapy (49)
Cervical cancer (2)
Clinical research (3239)
Collaboration (95)
Compensation (52)
COVID-19 (183)
CRISPR (8)
C-suite (31)
Cystic fibrosis (2)
Data (125)
Denatured (3)
Depression (3)
Diabetes (11)
Diagnostics (468)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4273)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6139)
Executive appointments (100)
FDA (505)
Funding (80)
Gene editing (15)
Gene therapy (22)
GLP-1 (61)
Government (153)
Guidances (1)
Healthcare (717)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (2)
Infectious disease (188)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (998)
IRA (7)
Job creations (295)
Job search strategy (66)
Kidney cancer (4)
Labor market (4)
Layoffs (39)
Leadership (1)
Legal (220)
Liver cancer (6)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (20)
MASH (4)
Medical device (333)
Medtech (333)
Mergers & acquisitions (1165)
Metabolic disorders (35)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (98)
NextGen: Class of 2025 (362)
Non-profit (164)
Now hiring (4)
Obesity (17)
Opinion (16)
Ovarian cancer (10)
Pain (10)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (5)
Peanut (1)
People (5708)
Pharmaceutical (5)
Phase I (1380)
Phase II (1630)
Phase III (869)
Pipeline (87)
Policy (12)
Postmarket research (31)
Preclinical (601)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (24)
Real estate (424)
Recruiting (5)
Regulatory (820)
Reports (6)
Research institute (144)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (12)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (490)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
Vaccines (29)
Venture capitalists (8)
Weight loss (13)
Women's health (2)
Worklife (1)
Date
Today (17)
Last 7 days (89)
Last 30 days (256)
Last 365 days (2585)
2025 (881)
2024 (2632)
2023 (2883)
2022 (3791)
2021 (4088)
2020 (3501)
2019 (2103)
2018 (1582)
2017 (1812)
2016 (1646)
2015 (1855)
2014 (1393)
2013 (1199)
2012 (1419)
2011 (1345)
2010 (1192)
Location
Africa (44)
Alabama (1)
Arizona (15)
Asia (1881)
Australia (301)
California (885)
Canada (138)
China (42)
Colorado (21)
Connecticut (10)
Delaware (4)
Europe (3879)
Florida (44)
Georgia (6)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (8)
Kansas (12)
Maryland (26)
Massachusetts (323)
Michigan (9)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (75)
New Mexico (1)
New York (53)
North Carolina (92)
Northern California (385)
Ohio (28)
Oklahoma (2)
Oregon (5)
Pennsylvania (54)
Rhode Island (2)
South America (41)
South Carolina (1)
Southern California (373)
Tennessee (2)
Texas (75)
United States (1839)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
38,781 Results for "sprint bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
October 24, 2024
·
11 min read
Press Releases
Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health
October 24, 2024
·
6 min read
Business
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
Day One Biopharmaceuticals today announced it has entered into an exclusive, worldwide license agreement and research collaboration with Sprint Bioscience for its VRK1 program.
August 16, 2023
·
4 min read
BioMidwest
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
SPR Therapeutics announced the publication of a multicenter double-blind randomized, placebo-controlled trial of individuals experiencing moderate-to-severe postoperative pain following knee replacement and treatment with the SPRINT PNS System.
May 13, 2024
·
6 min read
BioMidwest
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee PainPain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment
SPR Therapeutics announced the publication of a multicenter double-blind randomized, placebo-controlled trial of individuals experiencing moderate-to-severe postoperative pain following knee replacement and treatment with the SPRINT PNS System.
May 14, 2024
·
6 min read
Press Releases
SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting
November 21, 2024
·
8 min read
BioMidwest
SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain
SPR Therapeutics, Inc. announced the final patient was enrolled in the RESET Clinical Trial of SPRINT® PNS for the treatment of chronic low back pain.
December 12, 2023
·
4 min read
BioMidwest
SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
SPR® Therapeutics announced the 20,000th patient implant of the SPRINT® PNS System.
August 22, 2023
·
5 min read
Press Releases
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
July 16, 2024
·
5 min read
BioMidwest
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
SPR® Therapeutics announced the introduction of the SPRINT extensa XT System with bimodal peripheral nerve stimulation (PNS), designed to deliver a comprehensive approach to the alleviation of pain by treating dual nerve targets with synergistic stimulation modalities.
April 25, 2023
·
3 min read
1 of 3,879
Next
